- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 27.06. | VENUS MEDTECH-B (02500): TERMS OF REFERENCE OF THE NOMINATION COMMITTEE OF THE BOARD OF DIRECTORS | 1 | HKEx | ||
| 27.06. | VENUS MEDTECH-B (02500): LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS | 1 | HKEx | ||
| 27.06. | VENUS MEDTECH-B (02500): (1) POLL RESULTS OF THE 2024 ANNUAL GENERAL MEETING; AND (2) ELECTION OF CHAIRMAN OF THE BOARD AND MEMBERS OF COMMITTEES OF THE ... | 1 | HKEx | ||
| 05.06. | VENUS MEDTECH-B (02500): PROXY FORM FOR USE AT THE 2024 ANNUAL GENERAL MEETING | - | HKEx | ||
| 05.06. | VENUS MEDTECH-B (02500): NOTICE OF 2024 ANNUAL GENERAL MEETING | 2 | HKEx | ||
| 05.06. | VENUS MEDTECH-B (02500): (1) 2024 ANNUAL REPORT (2) WORK REPORT OF THE BOARD FOR 2024 (3) WORK REPORT OF THE SUPERVISORY COMMITTEE FOR 2024 (4) PROFIT ... | - | HKEx | ||
| VENUS MEDTECH Aktie jetzt für 0€ handeln | |||||
| 30.05. | VENUS MEDTECH-B (02500): (1) PROPOSED RE-ELECTION AND APPOINTMENT OF DIRECTORS FOR THE THIRD SESSION OF THE BOARD; AND (2) PROPOSED RE-ELECTION AND APPOINTMENT ... | - | HKEx | ||
| 29.04. | VENUS MEDTECH-B (02500): NOTIFICATION LETTER TO NON-REGISTERED HOLDERS - NOTICE OF PUBLICATION OF 2024 ANNUAL REPORT AND REPLY FORM | 2 | HKEx | ||
| 29.04. | VENUS MEDTECH-B (02500): NOTIFICATION LETTER TO REGISTERED SHAREHOLDERS - NOTICE OF PUBLICATION OF 2024 ANNUAL REPORT AND REPLY FORM | - | HKEx | ||
| 29.04. | VENUS MEDTECH-B (02500): 2024 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT | - | HKEx | ||
| 29.04. | VENUS MEDTECH-B (02500): 2024 ANNUAL REPORT | 1 | HKEx | ||
| 22.04. | Venus Medtech (Hangzhou) Inc.: Venus Medtech Reports 2024 Annual Results: Profitability Surges with Robust Global Expansion and Innovations | 384 | PR Newswire | HONG KONG, April 22, 2025 /PRNewswire/ -- Venus MedTech (Hangzhou) Inc. (Stock Code: 2500.HK, hereinafter referred to as "Venus Medtech" or the "Company"), a global leader in structural heart... ► Artikel lesen | |
| 28.03. | VENUS MEDTECH-B (02500): ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2024 | - | HKEx | ||
| 20.03. | VENUS MEDTECH-B (02500): PROPOSED ISSUE OF CONVERTIBLE BONDS UNDER GENERAL MANDATE | 2 | HKEx | ||
| 18.03. | VENUS MEDTECH-B (02500): DATE OF BOARD MEETING | - | HKEx | ||
| 14.03. | China's Venus Medtech Goes Live Again With 69% Plunge After Embezzlement | 1 | Yicai Global | ||
| 12.03. | VENUS MEDTECH-B (02500): FULFILLMENT OF ALL RESUMPTION GUIDANCE AND RESUMPTION OF TRADING | 1 | HKEx | ||
| 21.02. | VENUS MEDTECH-B (02500): (1) THE FIFTH QUARTERLY UPDATE ON RESUMPTION PROGRESS; AND (2) CONTINUED SUSPENSION OF TRADING | 3 | HKEx | ||
| 05.09.24 | Venus Medtech (Hangzhou) Inc.: Venus Medtech Venus-Vitae Completes First Two Implantations in SMART-ALIGN Pivotal Clinical Study | 293 | PR Newswire | HANGZHOU, China, Sept. 5, 2024 /PRNewswire/ -- Venus Medtech (Hangzhou) Inc. (Venus Medtech, 02500.HK), a leading provider of integrated solutions for transcatheter structural heart valvular... ► Artikel lesen |
19 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 49,590 | +2,18 % | Chinas Griff nach dem Rohstoffmarkt wackelt - und dieses Unternehmen steht bereit, die Lücke zu füllen! | ||
| GENEDX | 91,66 | 0,00 % | Why GeneDx Holdings Stock Blasted 8% Higher Today | ||
| PHETON | 1,630 | 0,00 % | CN ADR Pheton Plummets 95% in Single Day; Report Suggests Possible Manipulation by Overseas Groups | ||
| PRIVIA HEALTH GROUP | 19,480 | 0,00 % | Privia Health Group, Inc.: Privia Health Reports First Quarter 2025 Financial Results | Strong First Quarter Performance and Operating ExecutionEnters the State of ArizonaFull-Year 2025 Outlook Raised to Mid- to High End of Guidance Ranges for All Metrics with Attributed Lives Unchanged... ► Artikel lesen | |
| FRESENIUS | 42,560 | +0,61 % | Fresenius erhält EU-Zulassung für zwei Denosumab-Biosimilars | DJ Fresenius erhält EU-Zulassung für zwei Denosumab-Biosimilars
DOW JONES--Fresenius hat nach eigener Aussage die Zulassung der EU-Kommission für zwei Biosimilars in Europa erhalten.
Wie Fresenius... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 4,130 | 0,00 % | LifeStance Health (LFST) Appoints Vaughn Paunovich as Chief Technology Officer | ||
| FRESENIUS MEDICAL CARE | 45,290 | +0,07 % | Fitch bestätigt Fresenius Medical Care mit "BBB-" - Ausblick stabil | DJ Fitch bestätigt Fresenius Medical Care mit "BBB-" - Ausblick stabil
DOW JONES--Fitch Ratings hat die Langfrist-Ratings von Fresenius Medical Care (FMC) mit "BBB-" bestätigt. Der Rating-Ausblick... ► Artikel lesen | |
| GERRESHEIMER | 45,180 | -2,00 % | Evotec, Gerresheimer, Hugo Boss, Puma, Renk Group, Zalando - Aktien-Positionen der Short-Seller | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 53,85 | 0,00 % | PROCEPT BioRobotics President and CEO Dr. Reza Zadno to Retire, Company Appoints Larry L. Wood as New President and CEO | Larry L. Wood to join PROCEPT BioRobotics effective September 2, 2025Company confirms strong underlying business trends and pre-announces 2Q25 revenue of approximately $79.2 million, representing... ► Artikel lesen | |
| MIMEDX | 6,670 | 0,00 % | SA analyst upgrades/downgrades: OXY, AMZN, MDXG, CHTR | ||
| CARL ZEISS MEDITEC | 50,70 | -0,88 % | Carl Zeiss Meditec Aktie: Platzt am Montag die Bombe? Diese Neuigkeiten müssen Anleger dringend beachten! | ||
| ALIGNMENT HEALTHCARE | 11,780 | 0,00 % | Insights into Alignment Healthcare's Upcoming Earnings | ||
| UNITEDHEALTH | 228,95 | +1,15 % | Kriminelle Machenschaften: UnitedHealth: Nun also doch! | © Foto: UnsplashIm Mai hatte der US-Krankenversicherer UnitedHealth noch dementiert, dass das US-Ministerium gegen das Unternehmen ermitteln würde, nun ist es doch so. US-Krankenversicherer in der Krise... ► Artikel lesen | |
| NUTEX HEALTH | 84,90 | 0,00 % | Nutex Health, Inc.: Nutex Health Responds to Short Seller Report | HOUSTON, July 23, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system... ► Artikel lesen | |
| INCANNEX HEALTHCARE | 1,060 | 0,00 % | Pre-market Movers: Linkhome, Eightco Holdings, Incannex Healthcare, Coursera, NextCure | CANBERA (dpa-AFX) - The following are some of the stocks making big moves in Friday's pre-market trading (as of 07.35 A.M. ET).In the Green Linkhome Holdings Inc. (LHAI) is up over 120% at $12.40.
Eightco... ► Artikel lesen |
VENUS MEDTECH HANGZHOU INC gehört der Branche Gesundheitswesen an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu VENUS MEDTECH HANGZHOU INC finden Sie auf Wallstreet Online.